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The self-administered Food Allergy Quality of Life Questionnaire-Child Form 
(FAQLQ-CF), -Teenager Form (FAQLQ-TF) and -Adult Form (FAQLQ-AF) were 
recently developed within EuroPrevall, a multi-centred study of food allergy in 
Europe. The primary aim of this study was to evaluate the test-retest reliability of 
the FAQLQ-CF, -TF and -AF. 
Methods: 
One-hundred-and-one Dutch patients (31 children, 34 adolescents and 36 adults) 
completed the FAQLQ twice with a 10-14 day interval. The intraclass correlation 
coefficient (ICC), Lin’s concordance correlation coefficient (CCC) and Bland-
Altman plots were used to assess test-retest reliability.
Results: 
Test-retest reliability was excellent with ICCs and CCCs above 0.907, 0.975 and 
0.951 for the FAQLQ-CF, -TF and -AF, respectively. Bland-Altman plots showed that 
the mean differences of the test and retest were all close to zero for the FAQLQs. 
Conclusions: 
The FAQLQs are reliable over a short time interval. The FAQLQs are not only 
excellent tools for group comparison studies, but also for monitoring individual 
patients. 




Food allergy affects almost 4% of the general population in westernized countries 1 
and it is the primary cause of anaphylaxis presenting to emergency departments 2. 
The only proven therapy is careful avoidance of the causal food(s) and provision of 
medication for emergency treatment 3. Consequently, patients often fear an allergic 
reaction and are continuously faced with dietary and social restrictions in their 
daily lives, which can have a negative impact on quality of life 4-11. 
To measure Health-Related Quality of Life (HRQL), disease-specific ques-
tionnaires are significantly more sensitive than generic ones and they are important 
for estimating the general burden of food allergy as well as measuring the response 
to interventions or future treatments. However, generic HRQL instruments allow 
comparison of the burden of disease between patient populations with different 
diseases 12. Recently, as part of the EuroPrevall project, the first self-administered 
HRQL questionnaires specific for food allergy have been developed and validated; 
the Food Allergy Quality of Life Questionnaire-Child Form, -Teenager Form and 
-Adult Form (FAQLQ-CF, -TF, -AF). The FAQLQs showed good validity, internal 
consistency and discriminative abilities 13-16, but test-retest reliability was not ex-
tensively investigated.
Reliability measures are important to ensure that what the questionnaire is 
measuring is dependable and repeatable 12 and allow sample sizes to be determined 
for clinical trials 17. The aim of this study was therefore to assess the test-retest reli-
ability of the self-administered FAQLQ-CF, -TF and -AF. 
Methods
Patients
We contacted Dutch children (8-12 years), adolescents (13-17 years) and 
adults (>18 years) with food allergy, who were recruited from our clinic or by 
advertisement. We included patients with the most prevalent food allergies.
Questionnaires
The FAQLQ-CF contains 24 items and 4 domains, the FAQLQ-TF contains 23 items 
and 3 domains and the FAQLQ-AF contains 29 items and 4 domains 13-15. The total 
FAQLQ score is the sum of all the items divided by the number of items and ranges 
from 1 (minimal impairment in HRQL) to 7 (maximal impairment in HRQL) 18;19. 
     
Procedures
We sent the FAQLQs by mail to be completed at home. Regarding the FAQLQ-CF, 
parents were instructed that they were allowed to explain a question when needed, 
but they were not allowed to tell the child which answer to give. All patients who 
completed the first questionnaires (test) received the second questionnaires (re-
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test) 10-14 days after completion of the first. Patients who did not respond in time 
were excluded from the study 20;21 as well as patients who reported a clinically 
important change in disease between the measurements or within two months 
before the study. We defined a clinically important change in disease which 
may influence HRQL as a food allergic reaction of grade 3 or 4 according to the 
Mueller classification 22. The study was approved by the local medical ethics review 
commission (METc 2005/051). 
  
Statistical Analysis
Data were analysed using SPSS software for Windows (Version 14.0). To investigate 
test-retest reliability of the FAQLQs we used the intraclass correlation coefficient 
(ICC), using a one-way ANOVA 20;21;23. Values should be above 0.70 for group com-
parison studies and above 0.90-0.95 for individual measurements over time 24.  
As a second measure of test-retest reliability we calculated the Lin’s concor-
dance correlation coefficient (CCC). The different components of the CCC (Pearson 
correlation coefficient (measure of precision), location shift and scale shift (measures 
of accuracy)), were calculated. We plotted the first measurement against the second 
measurement and we used major axis analyses to calculate the best fitting line 25. 
Visual assessment of test-retest agreement was obtained by use of Bland-
Altman plots 26. Differences between the first and the second measurement were 
plotted against the mean of the first and the second measurement. Limits of agree-
ment (mean difference +/- 1.96*SD of the difference) were calculated, which 
reflect the interval within which about 95% of the differences between the two 
measurements should lie 27;28. A regression coefficient (r) was calculated to estimate 
a relationship between the difference and the mean 26. 
Results
Patients
We contacted 148 patients, of which 131 patients completed and returned the 
first questionnaire and 114 responded to the second questionnaire. This resulted 
in an overall response rate of 77%. A few patients were excluded, resulting in 
101 patients that were eligible for analysing test-retest reliability (Table 1). The 
descriptive characteristics are shown in table 2. Mean duration between the first 
and second measurement was 11 days for all three age groups.
Analysis of FAQLQs
ICCs were > 0.900 for the FAQLQs and CCCs were comparably high. Location shift 
and scale shift, should all be considered minimal according to Lin’s examples 29. 
Pearson correlation should be considered moderate in the FAQLQ-CF and good in 
the FAQLQ-TF and -AF (Table 3). Comparable results were found for the individual 
domains of the FAQLQs (data not shown). 
Test-retest reliability of the FAQLQs
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Table 1. Patient recruitment.  
Patients  Children            Adolescents        Adults Total
Contacted (n)       48                       51                        49 148
Returned 1st questionnaire (n) . 41                       47                        43 131 
Returned 2nd questionnaire (n) 38                       38                         38 114 
Excluded  (n) 7                         4                           2 13*
Analysed  (n) 31                       34                         36 101
* Seven patients (3 children, 3 adolescents, 1 adult) were excluded, because they completed the second 
questionnaire more than 14 days after completion of the first. One child and 1 adult were excluded because of 
a grade 3 or 4 allergic reaction between the first and second measurement. One child was excluded because 
she was aged under 8 years. Two children and 1 adolescent were excluded because they experienced their 
most severe reaction ever within 2 months before the first measurement.
Figure 1 illustrates the correlation between the first and second measurement. 
Major axis analysis revealed no significant differences of the slope and intercept of 
the best fitting line from the concordance line for the FAQLQ-CF and -TF. For 
the FAQLQ-AF there were significant but modest differences of the slope (1.10, 
p=0.046) and the intercept (-0.612, p=0.019) of the best fitting line from the 
concordance line. The slope and intercept of the best fitting line of the FAQLQ-CF, 
-TF and -AF did not differ significantly from each other.   
The Bland-Altman plots are shown in figure 2. About 95% of the differences 
lie within the 1.96 SD limits of agreement. There was no significant correlation 
between the mean of both scores and the differences of both scores for the FAQLQ-
CF and -TF. There was a significant but modest correlation between the mean 
of both scores and the differences of both scores for the FAQLQ-AF (r=-0.334; 
p=0.046). No significant systematic bias was observed, which means that mean 
differences of both scores were all close to zero. The limits of agreement are most 
narrow for FAQLQ-TF and wider for FAQLQ-CF and -AF.
Discussion
This article describes the evaluation of the test-retest reliability of the recently 
developed self-administered FAQLQ-CF, -TF and -AF. Overall, reliability was 
considered to be excellent for the FAQLQs as measured with the ICC and CCC. 
Additionally, Bland-Altman plots showed that mean differences were all close to 
zero, supporting the high reliability of the FAQLQs.
In this study we used ICCs calculated by a one-way ANOVA, CCCs and Bland-
Altman plots to assess test-retest reliability. However, different methods can be used 
to assess test-retest reliability and there is much discussion in literature on the 
best way to do this 20. A disadvantage of the ICC is that if patient groups are very 
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Table 2. Demographics and clinical characteristics.
Children (n=31) Adolescents (n=34) Adults (n=36)
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1 Other food allergy types not specified in the Mueller Classification, for example the Oral Allergy Syndrome.
2 Allergist, Dermatologist or Paediatrician
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homogeneous, the ICC tends to be low, because the ICC compares variance among 
patients to total variance. If patient groups are very heterogeneous, the ICC tends to 
be high. Thus, the ICC would only generalize to similar populations. Additionally, 
the one-way ICC does not take into account the order in which observations were 
taken 29. Therefore, the CCC is a useful additional measure. The CCC takes into 
account not only mean differences between the first and second measurement, 
such as ICCs calculated by a one-way ANOVA, but also takes into account variance 
differences between the first and second measurement by reducing the magnitude 
of the resulting test-retest reliability estimate. In addition, the CCC is a better tool 
to distinguish between bias and imprecision 20;29. There can be large differences in 
ICC and CCC scores, especially in studies with heterogeneous groups. The similar 
scores we found in our study reflect that both coefficients worked very well in 
this population and that results can be generalized to other groups. Bland-Altman 
plots are very illustrative in assessing test-retest agreement. They were useful to 
identify some extreme and outlying differences, to analyse the magnitude of the 
measurement error, which was small, and to visualize a possible relationship 
between the difference and the mean of both scores 26.  
Table 3. Reliability and agreement measures of the FAQLQs. 
                             FAQLQ-CF FAQLQ-TF FAQLQ-AF 
M1 (SD) 4.13 (1.15) 4.37 (1.20) 4.49 (1.44)
M2 (SD) 4.08 (1.34) 4.42 (1.29) 4.34 (1.59)
MB (SD) 4.11 (1.22) 4.40 (1.24) 4.41 (1.50)
MD (SD) 0.045 (0.537) -0.051 (0.274) 0.147 (0.451)
Limits of agreement (1.96*SD) -1.008  to  1.097 -0.588  to  0.486 -0.737  to  1.031  
ICC one-way (95% CI) 0.910 (0.823-0.955) 0.976 (0.952-0.988) 0.952 (0.909-0.975)
    Error variance 0.147 0.038 0.102
CCC (95% CI) 0.907 (0.847-0.967) 0.975 (0.959-0.991) 0.951 (0.921-0.981)
    Scale shift 1.162 1.077 1.104 
    Location shift 0.036 -0.041 0.097
    Pearson 0.918 0.978 0.960 
Kendall’s tau-b 0.759 0.888 0.780
M 1 = Total FAQLQ score measurement 1 
M 2 = Total FAQLQ score measurement 2   
MB = Mean FAQLQ score of both measurements
MD = Mean difference between measurement 1 and 2 (M1-M2)
SD = Standard deviation 
CI = Confidence interval
Limits of agreement: MD +/- 1.96*SD of the MD
ICC = Intraclass correlation coefficient
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Figure 1. FAQLQ score of the first 
measurement against FAQLQ score 
of the second measurement with 
45º line through the origin in A 
children, B adolescents and C 
adults.
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Figure 2. Bland-Altman plots 
for the FAQLQs in A children, B 
adolescents and C adults. The 
mean of both measurements are 
plotted against the difference of 
both measurements (calculated as 







This study may also have some limitations. Firstly, the sample sizes were 
relatively small. However, we found that the reliability of the questionnaires was 
very high, which indicates that the sample sizes were adequate and that a greater 
number of patients would probably not have influenced the outcomes. Another 
limitation may be that the majority of adults in this study was female. However, we 
did not find significant differences in the test-retest reliably outcomes between men 
and women (data not shown). Therefore, we think that the imbalance between men 
and women did not influence the generalisability of the results of the FAQLQ-AF. 
Finally, the significant correlation between the first and second measurement of the 
FAQLQ-AF (figure 1C) and between the mean of both scores and the differences 
of both scores of the FAQLQ-AF (figure 2C) was an unexpected finding. We think 
this correlation might be due to an outlier. This assumption was supported by a 
re-analysis excluding this outlier, which showed that the correlation was no longer 
significant.
In summary, the FAQLQs clearly showed excellent reliability and are thus 
promising measures in evaluative studies in patients with food allergy, but also in 
monitoring individual patients. The high test-retest reliability supports the value of 
the FAQLQs for clinical trials with relatively small sample sizes. We recommend the 
use of the FAQLQs in clinical trials of current management strategies of food allergy 
and they may also be useful when new treatments become available. Currently, the 
longitudinal validity of the FAQLQs and the validity of several other European 
language versions of the FAQLQs are being investigated.
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